Overview
Neuralstem develops neural stem cell-based therapies and small-molecule compounds targeting neurological conditions including ALS and spinal cord injury.
More in Neuropharmaceuticals
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-07-27 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-26 · Funding
ReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics
2026-07-25 · Funding
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
2026-07-24 · Funding
Company details
Category
💊 Neuropharmaceuticals
Location
Germantown, MD, USA
Funding
Publicly traded (NASDAQ: CUR)
Website
www.neuralstem.comListed
2026-07-06
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →